Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
C-squared Pharma
C-squared Pharma
Activities:
Ingredients
Trending Articles
Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings
The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end...
UK liquid manufacturing: why British production matters for healthcare and the economy
How specialist liquid manufacturing in Newcastle supports UK healthcare supply chains, skilled employment and pharmaceutical and nutraceutical production
From speed to strategy: how UK life sciences should respond to China’s rise
A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent dinner sponsored by AsymChem to discuss a question now...
Pope Scientific: The industry’s leading custom Agitated Nutsche Filter Dryer provider
Pope Scientific manufactures custom and stock Agitated Nutsche Filter Dryers (ANFD) for high-purity solid-liquid separation, washing, re-slurrying and vacuum drying within a...
Why CAPA keeps failing and what strong organisations do differently
This white paper examines why CAPA systems often close records without preventing recurrence, tracing breakdowns to investigation quality, risk reasoning, and organisational...
Related Content
Ingredients
C2 Pharma launches brinzolamide ophthalmic API
C2 Pharma has added brinzolamide to its ophthalmic API portfolio following completion of process validation and submission of a US Drug Master File
Manufacturing
C2 PHARMA receives CEP approval for Oxybuprocaine hydrochloride
C2 PHARMA proudly announces the approval of a Certificate of Suitability (CEP) for Oxybuprocaine hydrochloride by the European Directorate for the Quality of Medicines and Health Care (EDQM)
Manufacturing
C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs
The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide
Ingredients
C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch
C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride
Regulatory
C2 Pharma's Tropicamide receives CEP from the European Directorate
The CEP approval of the ophthalmic drug allows C2 Pharma to distribute Tropicamide globally
Ingredients
C2 PHARMA announces upcoming launch of new oxybuprocaine hydrochloride API
C2 PHARMA excited to announce the upcoming launch of its new API, oxybuprocaine HCL, an ingredient that will be manufactured by manufacturing partner Laurus Labs
Ingredients
C2 Pharma to participate in DCAT Week 2024
The C2 PHARMA team will be located in the Benjamin hotel in Suite 2202
Subscribe now